{
  "docId": "019de073-5c75-763a-a0f1-d995dc5da488",
  "docSlug": "01bee26c2c6ee992ec5e01a8e02dc689",
  "documentTitle": "Myovant Sciences | Results Presentation Deck | 34 slides",
  "authorId": "myovant-sciences",
  "authorName": "Myovant Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 34,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a split-screen layout to contrast 'Today' vs 'Tomorrow' strategic focus areas.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-5c75-763a-a0f1-d995dc5da488/32",
  "deckHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488",
  "deckJsonHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488.json",
  "deckAnchorHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "NBRx = New-to-Brand Prescription; TRx = Total Prescriptions; GnRH = Gonadotropin-releasing Hormone; FDA = U.S. Food and Drug Administration; sNDA = Supplemental New Drug Application; PDUFA = Prescription Drug User Fee Act; EMA = European Medicines Agency",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "886f9eb6-1b50-452e-bea0-6cdf4b0ab90d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.38,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Delivering for Today: ORGOVYX growth, MYFEMBREE market share expansion, strategic partnerships, and financial position.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d48e683b-fdf3-42ba-b50c-9ba5ad1bf550",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.5,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "list",
      "text": "While Building for Tomorrow: EMA submissions, Health Canada submissions, European launches, FDA reviews, and new pipeline programs.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f87c78f4-a785-41a1-bf08-824ed7dfc47f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.75,
        "x": 0.12,
        "y": 0.05
      },
      "kind": "title",
      "text": "Positioned to Deliver on Key Growth Drivers",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46503454-1029-49a3-a189-8fe8fabc3a9a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "61afe6ec-1567-4371-b7e7-87f754db557b",
      "evidence": "The slide explicitly contrasts 'Delivering for Today' with 'While Building for Tomorrow'.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}